Abstract:Silica nanoparticles are increasingly considered for drug delivery applications. These applications require an understanding of their biocompatibility, including their interactions with the immune system. However, systematic studies for silica nanoparticle immunological safety profiles are lacking. To fill this gap, we conducted an in vitro study investigating various aspects of silica nanoparticles' interactions with blood and immune cells. Four types of silica nanoparticles with variations in size and porosity were studied. These included nonporous Stöber silica nanoparticles with average diameters of approximately 50 and 100 nm (SNP50 and SNP100), mesoporous silica nanoparticles of approximately 100 nm (Meso100), and hollow mesoporous silica nanoparticles of approximately 100 nm (HMSNP100) in diameter, respectively. The hematological compatibility was assessed using hemolysis, complement activation, platelet aggregation, and plasma coagulation assays. The effects of nanoparticles on immune cell function were studied using in vitro phagocytosis, chemotaxis, natural killer cell cytotoxicity, leukocyte proliferation, human lymphocyte activation, colony-forming unit granulocyte-macrophage, and leukocyte procoagulant activity assays. The in vitro findings suggest that at high concentrations, corresponding to the in vivo human dose of 40 mg/kg, silica nanoparticles demonstrated an array of immunotoxic effects that depended on their physicochemical properties. However, all types of silica nanoparticles studied were not immunotoxic at concentrations corresponding to lower doses (≤ 8 mg/kg) comparable to that of nanocarriers in other nanomedicines currently used in the clinic. These findings are promising for using silica nanoparticles for the systemic delivery of bioactive and imaging agents.

Biocompatibility of 2D silicon nitride: interaction at the nano-bio interface

Superior Compatibility Of C2n With Human Red Blood Cell Membranes And The Underlying Mechanism

Effects of nano-sized silicon dioxide on the structures and activities of three functional proteins

Computational Studies on the Interactions of Nanomaterials with Proteins and Their Impacts

Structural Consequences of the Villin Headpiece Interaction with a Carbon Nitride Polyaniline (C3N) Nanosheet

Multi-scale Simulations on Biocompatibility of Boron Nitride Nanomaterials with Different Curvatures: A Comparative Study

Cytotoxicity of Graphene: Recent Advances and Future Perspective.

Mild Binding of Protein to C2N Monolayer Reveals Its Suitable Biocompatibility

Boron Nitride Nanosheets Can Induce Water Channels Across Lipid Bilayers Leading to Lysosomal Permeabilization

Nanobio Interface Between Proteins and 2D Nanomaterials

Sustainable Synthesis of Highly Biocompatible 2D Boron Nitride Nanosheets

Biomacromolecular and Toxicity Responses of Bacteria Upon the Nano-Bio Interfacial Interactions with Ti3C2Tx Nanosheets

Molecular interpretation of the carbon nitride performance as a template for the transport of anti-cancer drug into the biological membrane

Influence of Surface Charge on the Functional Properties of Silica Nanoparticles and Cellular Toxicity

Immunological properties of silica nanoparticles: a structure-activity relationship study

Influence of Geometry, Porosity, and Surface Characteristics of Silica Nanoparticles on Acute Toxicity: Their Vasculature Effect and Tolerance Threshold.

Differential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell lines

Interaction between U-shaped amyloid beta fibril and semiconducting silicon nitride monolayer

The Interfacial Interactions of Nanomaterials with Human Serum Albumin.

Silicon nanostructures toxicity. An ab inito approach

Silicon nanostructures and nanocomposites for antibacterial and theranostic applications